The Federal Government has trained scientists drawn from key research institutions across the country on mRNA technology ...

A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...

Researchers at MIT have unveiled a way to temporarily reboot aging immune systems, using a targeted mRNA therapy that turns ...

A black-box warning is not a neutral informational update. It is the FDA’s most aggressive regulatory communication via product labeling, intended to alert clinicians and patients to risks so grave ...

Every cell in the body makes both RNA and peptides. But what emerges here is not just a story about molecules, but about ...

Given the vomiting and diarrhea, the biggest risk with norovirus is dehydration, which can turn a short-term illness into a ...

The era of CureVac as an independent, publicly traded company has drawn to a close. BioNTech SE has successfully completed ...

As the immune system weakens with age, researchers have found a way to temporarily boost its function by reprogramming liver cells to support T-cell development.

The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

Testing in mice suggests that rejuvenating T cells could make vaccines and some cancer therapies more effective.

The Coalition for Epidemic Preparedness Innovations said it will invest $54.3 million with Moderna to fund a Phase 3 trial of ...